•
Jun 30, 2017

EyePoint Pharmaceuticals Q4 2017 Earnings Report

Total Revenue
$701K
Previous year: $304K
+130.6%
EPS
-$1.6
Previous year: -$1.9
-15.8%
Gross Profit
$701K
Previous year: -$3.8M
-118.4%
Cash and Equivalents
$16.9M
Previous year: $15.3M
+10.4%
Free Cash Flow
-$20.6M
Previous year: -$16.4M
+26.0%
Total Assets
$18.7M
Previous year: $31.6M
-40.9%

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals